Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy

13Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel functional-genomics based concept of pharmacology that uses artificial intelligence techniques for mining and knowledge discovery in "big data" providing comprehensive information about the drugs' targets and their functional genomics is proposed. In "process pharmacology", drugs are associated with biological processes. This puts the disease, regarded as alterations in the activity in one or several cellular processes, in the focus of drug therapy. In this setting, the molecular drug targets are merely intermediates. The identification of drugs for therapeutic or repurposing is based on similarities in the high-dimensional space of the biological processes that a drug influences. Applying this principle to data associated with lymphoblastic leukemia identified a short list of candidate drugs, including one that was recently proposed as novel rescue medication for lymphocytic leukemia. The pharmacological data science approach provides successful selections of drug candidates within development and repurposing tasks.

Cite

CITATION STYLE

APA

Lötsch, J., & Ultsch, A. (2016). Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy. CPT: Pharmacometrics and Systems Pharmacology, 5(4), 192–200. https://doi.org/10.1002/psp4.12072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free